位置:首页 > 蛋白库 > PENN_PENTH
PENN_PENTH
ID   PENN_PENTH              Reviewed;        2797 AA.
AC   A0A1B2CTC5;
DT   25-MAY-2022, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2016, sequence version 1.
DT   03-AUG-2022, entry version 29.
DE   RecName: Full=Nonribosomal peptide synthetase penN {ECO:0000303|PubMed:25859931};
DE            Short=NRPS penM {ECO:0000303|PubMed:25859931};
DE            EC=6.3.2.- {ECO:0000305|PubMed:25859931};
DE   AltName: Full=Penigequinolones biosynthesis cluster protein N {ECO:0000303|PubMed:25859931};
GN   Name=penN {ECO:0000303|PubMed:25859931};
OS   Penicillium thymicola.
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Penicillium.
OX   NCBI_TaxID=293382;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, DISRUPTION PHENOTYPE, AND
RP   PATHWAY.
RC   STRAIN=IBT 5891 / CBS 111225;
RX   PubMed=25859931; DOI=10.1021/jacs.5b03022;
RA   Zou Y., Zhan Z., Li D., Tang M., Cacho R.A., Watanabe K., Tang Y.;
RT   "Tandem prenyltransferases catalyze isoprenoid elongation and complexity
RT   generation in biosynthesis of quinolone alkaloids.";
RL   J. Am. Chem. Soc. 137:4980-4983(2015).
RN   [2]
RP   FUNCTION.
RX   PubMed=28114276; DOI=10.1038/nchembio.2283;
RA   Zou Y., Garcia-Borras M., Tang M.C., Hirayama Y., Li D.H., Li L.,
RA   Watanabe K., Houk K.N., Tang Y.;
RT   "Enzyme-catalyzed cationic epoxide rearrangements in quinolone alkaloid
RT   biosynthesis.";
RL   Nat. Chem. Biol. 13:325-332(2017).
CC   -!- FUNCTION: Nonribosomal peptide synthetase; part of the gene cluster
CC       that mediates the biosynthesis of penigequinolones, potent insecticidal
CC       alkaloids that contain a highly modified 10-carbon prenyl group
CC       (PubMed:25859931). The first stage is catalyzed by the nonribosomal
CC       pepdide synthetase penN that condenses anthranilic acid and O-methyl-L-
CC       tyrosine to produce 4'-methoxycyclopeptin (By similarity). 4'-
CC       methoxycyclopeptin is then converted to 4'-methoxydehydrocyclopeptin by
CC       the ketoglutarate-dependent dioxygenase penM through dehydrogenation to
CC       form a double bond between C-alpha and C-beta of the O-methyltyrosine
CC       side chain (By similarity). PenM also converts its first product
CC       methoxydehydrocyclopeptin to 4'-methoxycyclopenin (By similarity). The
CC       following conversion of 4'methoxycyclopenin into 4'-methoxyviridicatin
CC       is catalyzed by the cyclopenase penL (By similarity). 4'-
CC       methoxyviridicatin is the precursor of quinolone natural products, and
CC       is further converted to quinolinone B (Probable). The prenyltransferase
CC       penI then catalyzes the canonical Friedel-Crafts alkylation of
CC       quinolinone B with dimethylallyl cation to yield dimethylallyl
CC       quinolone, which is subjected to FAD-dependent dehydrogenation by the
CC       FAD-linked oxidoreductase penH to yield conjugated aryl diene
CC       (PubMed:25859931). The delta(3') double bond then serves as the site of
CC       the second alkylation with DMAPP catalyzed by the prenyltransferase
CC       penG to yield a carbenium ion intermediate, which can be attacked by
CC       H(2)O to yield a styrenyl quinolone containing a C3'-hydroxyprenyl
CC       chain, or undergo cyclization to yield yaequinolones J1 and J2
CC       (PubMed:25859931). The conversion of the styrenyl quinolone into the
CC       tetrahydrofuran-containing yaequinolone C is performed by the FAD-
CC       dependent monooxygenase penE and involves epoxidation of the terminal
CC       C7'-C8' olefin, followed by epoxide ring opening initiated by the C3'
CC       hydroxyl group (PubMed:25859931). The predicted cysteine hydrolase penJ
CC       acts as an epoxide hydrolase that enhances the rate of the 5-exo-tet
CC       cyclization step, increasing the yield of yaequinolone C
CC       (PubMed:25859931, PubMed:28114276). PenF catalyzes the cationic
CC       rearrangement of the epoxide formed by penE (before ring opening to
CC       produce yaequinolone C) into yaequinolone D (PubMed:28114276). Finally,
CC       the short-chain dehydrogenase/reductase (SDR)-like reductase penD,
CC       catalyzes both the dehydration of yaequinolone D and the reduction of
CC       the resulting oxonium to yield penigequinolone (PubMed:28114276).
CC       {ECO:0000250|UniProtKB:C8VJQ3, ECO:0000250|UniProtKB:Q5AR53,
CC       ECO:0000250|UniProtKB:Q5AR54, ECO:0000269|PubMed:25859931,
CC       ECO:0000269|PubMed:28114276, ECO:0000305|PubMed:25859931}.
CC   -!- PATHWAY: Secondary metabolite biosynthesis.
CC       {ECO:0000269|PubMed:25859931}.
CC   -!- PATHWAY: Alkaloid biosynthesis. {ECO:0000269|PubMed:25859931}.
CC   -!- PATHWAY: Mycotoxin biosynthesis. {ECO:0000269|PubMed:25859931}.
CC   -!- DOMAIN: NRP synthetases are composed of discrete domains (adenylation
CC       (A), thiolation (T) or peptidyl carrier protein (PCP) and condensation
CC       (C) domains) which when grouped together are referred to as a single
CC       module. Each module is responsible for the recognition (via the A
CC       domain) and incorporation of a single amino acid into the growing
CC       peptide product. Thus, an NRP synthetase is generally composed of one
CC       or more modules and can terminate in a thioesterase domain (TE) that
CC       releases the newly synthesized peptide from the enzyme. Occasionally,
CC       methyltransferase domains (responsible for amino acid methylation) are
CC       present within the NRP synthetase. PenN has the following
CC       architecture:A-T-C-A-M-T-C. {ECO:0000305|PubMed:25859931}.
CC   -!- DISRUPTION PHENOTYPE: Abolishes the production of penigequinolones A
CC       and B. {ECO:0000269|PubMed:25859931}.
CC   -!- SIMILARITY: Belongs to the NRP synthetase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KX528209; ANY57892.1; -; Genomic_DNA.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   GO; GO:0043604; P:amide biosynthetic process; IEA:UniProt.
DR   GO; GO:1901566; P:organonitrogen compound biosynthetic process; IEA:UniProt.
DR   Gene3D; 1.10.1200.10; -; 1.
DR   Gene3D; 3.30.300.30; -; 3.
DR   Gene3D; 3.30.559.10; -; 2.
DR   Gene3D; 3.40.50.12780; -; 2.
DR   Gene3D; 3.40.50.150; -; 1.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR010071; AA_adenyl_domain.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR045851; AMP-bd_C_sf.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; ANL_N_sf.
DR   InterPro; IPR023213; CAT-like_dom_sf.
DR   InterPro; IPR001242; Condensatn.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   Pfam; PF00501; AMP-binding; 2.
DR   Pfam; PF00668; Condensation; 2.
DR   Pfam; PF00550; PP-binding; 2.
DR   SMART; SM00823; PKS_PP; 2.
DR   SUPFAM; SSF47336; SSF47336; 2.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   TIGRFAMs; TIGR01733; AA-adenyl-dom; 2.
DR   PROSITE; PS00455; AMP_BINDING; 2.
DR   PROSITE; PS50075; CARRIER; 2.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 1.
PE   3: Inferred from homology;
KW   Ligase; Phosphopantetheine; Phosphoprotein; Repeat.
FT   CHAIN           1..2797
FT                   /note="Nonribosomal peptide synthetase penN"
FT                   /id="PRO_0000455370"
FT   DOMAIN          751..824
FT                   /note="Carrier 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          2277..2351
FT                   /note="Carrier 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   REGION          239..625
FT                   /note="Adenylation 1"
FT                   /evidence="ECO:0000255"
FT   REGION          830..856
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          870..1299
FT                   /note="Condensation 1"
FT                   /evidence="ECO:0000255"
FT   REGION          1328..1731
FT                   /note="Adenylation 2"
FT                   /evidence="ECO:0000255"
FT   REGION          1857..1953
FT                   /note="Methyltransferase"
FT                   /evidence="ECO:0000255"
FT   REGION          2516..2658
FT                   /note="Condensation 2"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        841..856
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         785
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         2311
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ   SEQUENCE   2797 AA;  307817 MW;  9A6EDB04B5C690FD CRC64;
     MYHQLESHGV FPTLGDDAAK LVRTTHVQEI AFTPISEIQR FCEAQNISCD SFYLNVWSLV
     LRAFAETNSV CVGFGDFRPS GARLDQALFK ILQTTLSPKS SILSILQGFK QDERAFSVNH
     REPAHNTGVV FISEASGPLD LASLGKLKYD LLMVVSFDSK SIPISLFLVY RPSTLSQSHA
     ENLSSNITQA MQQVLARPNS FVNDVELFST FNKSLVLCWN GLERKAASLL EVIQGHVRSR
     PDHPAICAWD GTISYSQLDM LTTQWASYLQ SRGVQPGCLV PIMMEHSKWA IIGEIAILKA
     GAAFVPIDPA HPVSRLKGIV QRTKANIAVS SGHLIDKLSS LVDTVVEISD QTTSGLPEAV
     RHGAANPVPF DRTAYVLFTS GSTGQPKGCV VSYRALSDVV HQTTALNIDS ESRVLQFASY
     TYGMSLIEVH CTLAAGATIC IPSDYHRLNA LSSAIQSTQV TWAILTASTT LTIAETARYL
     RTLVVAGEPM GIDHVRSLAD KVELLQAFGL TEWGGICCVS QRIRSEGDVR LIGRSPTANL
     WLIDPTDGSK LAPVGAAAEL FVEGPALADG YLEDPHQTAA VFIKRPPWIP APTGVRLYRT
     GDLVRYTGDG NLLYIARKDS QVKIRGMRVE LGEVEYQIRQ AFPALGEAIA VATTTKESSG
     MPILAAFLHM ENQLDLSGQS FSHMIDTIKT SLRKTLPDYM WPSIYIPLDS VPLTISRKID
     RKDLQLRVQK STRMELEENQ VSSACIVAPL TDTERHVHRF VAELLHLDPL SFGMNQNFIN
     LGGDSVSAMR LVNKCKYQGY RVTVGEILEV RTLSDIVSLV RTATTSSSVP SAGAEISRSD
     APTESPATGS FEGSGYTTIP RLSQSGPIEQ SFSQARMWFL EELHPGSSWY ILPYATRLQG
     PLQLDHLEAA LSALSERHET LRTTFESRDG TGLQIVAPFR PKPLEVIEVT SDSSIAALRT
     ALQEQMKPFD LTKDTWRSAV LRLSPTDHVF SVVFHHIISD GWSVDVFMKT LETFYSAVIR
     GQPPLHITKP LQIQYRDFSI WQRQEQSRIH QKQIAYWIQQ LHGSKPAEFL CDKPRPTKPS
     IAAGSMDVKI DGELYQALQG FCRSRQVTPF TTLLAAFRTT HYRLTGASDA TIGIPSASRT
     RPELEELIGY FGNVQCIRTV IDSRGQSFQQ LVQQVQSATT AASQNQDVPF DQVVSRLLKD
     RDMSRHPLVQ VTFVLHPQAN FGQLHLEGLR AEHLHLPQVT RLDLEFHLYP GDGCLQGDIL
     YSADLFNPET IRTLRSVFYD VLSEGLCHPD IEIGSLLLTD AYPVLDQRGL IYTAHEAPFQ
     GCSIIDMFHQ QVAAHGDQMA IKDTHTQLTY CELDRRSDML ATWLKNSFLF VEETPVGVFG
     NRSCESIVTI LGILKAGLAY VPLDADAPPQ RTEMILSCLP SCQLVLLLSG LMAPPTLPSN
     IKFAYVSNSS DVKVEEVDAF LTHTPTPRAT NLAYIVFTSG TTGTPKGVMV EHRGVVRLAK
     DPEIVAHTRD FKVASHVLNP AFDASGFEVY ATLLNGGTLV CIDKNIVWDY AALGATLVKH
     GVQRAFFTTA VLKQCLLSAP YIMSDLEILY VGGDKLDPHD MAVARRFGKV RIFNVYGPTE
     NSVVSTRYAI PDGEAAVNGM PIGRSIAGSG AYVMDPNLRL VPIGAMGELV VTGLGLARGY
     TNPEQNIGRF VTVSIGGQVV HAYRTGDMVR YRPSDAQLEF FGRMDQQVKI RGYRVELAEI
     DNALALNSLV SSAVTVLQTQ EDQEQELVSF VTIQDTAANV ENLEEHISNA HVNSWKDHAE
     GGDHYGKLGA VDPATLGRDF LGWVSMYDGE AIDTEVMTEW LEDTIAAIHL CDAASALEIG
     TGTGMILFNL IDSLKEYYGL EPSRQAVEFV QRAVRCVPKA ASKVRIQQGT ASALVGLKAT
     GPIDLAVVNS VAQYFPSAKY MTRVIKQLIQ LHDLNCIFFG DIRSYGLYEE FQASKVLHLY
     GHTLSAREFS QKMAEIVQLE KELLIDPAFF TALATEFPEL IEHVEIMPKR MKTTNELSCY
     RYTAILHIRR PSQSLLVHEV EQSSWLDFEA SGLDYRSLTQ MLKTSNDVSV LAFSNIPFKK
     TIMERHVVNF LRHLPTGAGS AGWSMDVCQQ ALVCPAIDAT ELIDVAQLTG WQVEISWARQ
     HSQFGGLDAI FHRLKPEDNG SRVFFQFPTD HGRRGLSCAF SNDPLALQRN QRIENELLEN
     LRARLPSYMV PKRIRVLDRM PINNIGKVDR QALAKRVDIP PPAGVLTARS SPRNDMSFTD
     DIERAMWEEF AGVLGVEVGI ADSFFDCGGH SLMAIKLVSR INKRLQSTVP VSDLFQYPSV
     SRLAGRVRGF RAPSNSTVSY QPFSLLPGSL SRLPYIDSPY GSEPHLPPST EIIDMLPVTE
     SQAWFLADWS LVSHSFRIEG ALDVDGLRAA CQAVVRHHAT LRTVFTKLLG RLVQVVCGSV
     DAPFAHVYTD GDLESECRSL CAADGGAPSG LTTGFTLLSR STIEHIFILR FSHAQYDGIS
     LSSILSDLAA AYAGTAPLPT TAPFSGYVHV AALSRSVALD FWKKYLEGSV LTTLRPSNTA
     INARVVDLTR EAVGKLHQLA DITFPTIVNA AIAITLASLV KRNDVTFACV MSSRGVLSQG
     ADSVQGPCVN RTLIRVQLSP DSTALGFCRG LRKNQARVSA ENHLELGDVL ENCTSWSSSD
     RLAPWITHLP ADKATSTLAL PGACITYRST DVRINPRNQI LVRSVITDQQ QACIQVQVSS
     TVMDGSYAFS LASKILNTAQ ALSMSAERTL SSIDVHE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024